Invalid Symbol

Stock Research for RIGL

RIGL
Current Price

$


Latest Update:

High
$
Low
$
Close
$
Volume
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

RIGL Stock Chart & Research Data

The RIGL chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the RIGL chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


RIGL Due diligence Resources & Stock Charts

The RIGL stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View RIGL Detailed Price Forecast - CNN Money CNN View RIGL Detailed Summary - Google Finance
Yahoo View RIGL Detailed Summary - Yahoo! Finance Zacks View RIGL Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View RIGL Trends & Analysis - Trade-Ideas Barrons View RIGL Major Holders - Barrons
NASDAQ View RIGL Call Transcripts - NASDAQ Seeking View RIGL Breaking News & Analysis - Seeking Alpha
Spotlight View RIGL Annual Report - CompanySpotlight.com OTC Report View RIGL OTC Short Report - OTCShortReport.com
TradeKing View RIGL Fundamentals - TradeKing Charts View RIGL SEC Filings - Bar Chart
WSJ View Historical Prices for RIGL - The WSJ Morningstar View Performance/Total Return for RIGL - Morningstar
MarketWatch View the Analyst Estimates for RIGL - MarketWatch CNBC View the Earnings History for RIGL - CNBC
StockMarketWatch View the RIGL Earnings - StockMarketWatch MacroAxis View RIGL Buy or Sell Recommendations - MacroAxis
Bullish View the RIGL Bullish Patterns - American Bulls Short Pains View RIGL Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View RIGL Stock Mentions - StockTwits PennyStocks View RIGL Stock Mentions - PennyStockTweets
Twitter View RIGL Stock Mentions - Twitter Invest Hub View RIGL Investment Forum News - Investor Hub
Yahoo View RIGL Stock Mentions - Yahoo! Message Board Seeking Alpha View RIGL Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for RIGL - SECform4.com Insider Cow View Insider Transactions for RIGL - Insider Cow
CNBC View RIGL Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for RIGL - OTC Markets
Yahoo View Insider Transactions for RIGL - Yahoo! Finance NASDAQ View Institutional Holdings for RIGL - NASDAQ


Stock Charts

FinViz View RIGL Stock Insight & Charts - FinViz.com StockCharts View RIGL Investment Charts - StockCharts.com
BarChart View RIGL Stock Overview & Charts - BarChart Trading View View RIGL User Generated Charts - Trading View


Latest Financial News for RIGL

New Research: Key Drivers of Growth for SpartanNash, Nustar GP, Hornbeck Offshore Services, TiVo, Eli Lilly, and Rigel Pharmaceuticals — Factors of Influence, Major Initiatives and Sustained Production
Posted on Wednesday February 21, 2018

NEW YORK, Feb. 21, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of SpartanNash ...


Rigel Pharmaceuticals, Inc. Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
Posted on Friday February 16, 2018

SOUTH SAN FRANCISCO, Calif., Feb. 16, 2018 /PRNewswire/ -- Rigel Pharmaceuticals (RIGL) today announced that on January 24, 2018 the Compensation Committee of Rigel's Board of Directors approved the grant of inducement stock options to purchase an aggregate of 30,000 shares of common stock to one new employee. This award was granted pursuant to the Rigel Pharmaceuticals, Inc. Inducement Plan, as amended, as an inducement material to the new employee entering into employment with Rigel, in accordance with NASDAQ Listing Rule 5635(c)(4). Rigel granted stock options to purchase shares of Rigel's common stock to the employee with an exercise price of $3.79 per share, the closing price of Rigel's common stock on February 9, 2018, the first trading date prior to February 12, 2018, the effective date of such grant.


3 Small-Cap Biotech Stocks With Major Catalysts in 2018
Posted on Saturday January 06, 2018

Good news this year could make these small biotech stocks bigger.


Rigel to Provide Business Review and Updated Phase 2 Results for Fostamatinib in AIHA at the 36th Annual J.P. Morgan Healthcare Conference
Posted on Thursday January 04, 2018

SOUTH SAN FRANCISCO, Calif., Jan. 4, 2018 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (RIGL) today announced that Raul Rodriguez, the company's president and chief executive officer, will present an update on its product pipeline and a financial overview at the upcoming 36th Annual J.P. Morgan Healthcare Conference in San Francisco, California on January 10, 2018, at 1:30pm PST (see webcast details below). Rigel's presentation will include a review of the company's New Drug Application (NDA) for fostamatinib, an oral spleen tyrosine kinase (SYK) inhibitor, in adult patients with immune thrombocytopenia (ITP). The FDA has confirmed that it does not plan to convene an Oncology Drugs Advisory Committee (ODAC) meeting to discuss the NDA.  The action date for the FDA to complete its review is April 17, 2018 under the Prescription Drug User Fee Act (PDUFA).


Rigel: How To Play Ahead Of April Catalyst
Seeking Alpha - 14 hours ago
Rigel Pharmaceuticals (RIGL) has a major catalyst coming up in April. On April 17th, the FDA will decide on the New Drug Application (NDA) for Tavalisse (fostamatinib disodium) in ITP.

Risk Alert in Option Market: Rigel Pharmaceuticals Inc Implied Price Swing ...
CML News - 2 hours ago
Risk Alert: Before we dive into any analysis we simply note that Rigel Pharmaceuticals Inc (NASDAQ:RIGL) risk is at an extremely elevated level.

Rigel Pharmaceuticals, Inc. (RIGL) Holdings Trimmed by California State ...
The Ledger Gazette - 20 hours ago
Rigel Pharmaceuticals logo California State Teachers Retirement System trimmed its holdings in shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) by 8.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange ...
Rigel Pharmaceuticals' (RIGL) “Buy” Rating Reiterated at HC Wainwright - Dispatch Tribunal
Stocks That May Be Worth Big Bets: Rigel Pharmaceuticals, Inc. (RIGL), GasLog ... - Analyst Journal

Just the Facts on Rigel Pharmaceuticals, Inc. (RIGL)
StockNewsJournal - Feb 2, 2018
In recent action, Rigel Pharmaceuticals, Inc. (RIGL) has made a move of -0.99% over the past month, which has come on Strong relative transaction volume.

Enter a stock symbol to view the stock details.